• Tue, August 6, 2024

Marc Frahm Maintained (TBPH) at Hold with Decreased Target to $9 on, Aug 6th, 2024

Marc Frahm of TD Cowen, Maintained "Theravance Biopharma, Inc." (TBPH) at Hold with Decreased Target from $10 to $9 on, Aug 6th, 2024.

Marc has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.



This is the rating of the analyst that currently disagrees with Marc


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024